Isaac Klein
244 posts

Isaac Klein
@isaacbklein
Optimizing how humans think about their health | Co-Founder @whooshwellness



Earlier this week, Gallup said that 11% of US adults polled were using GLP-1s. There are around 267 million adults in the US. If that 11% number is “real”, that would be roughly 30 million US patients. The problem: in their last quarterly report (Q1 2026), $LLY said the US incretin market was around 2.4 million a week - or roughly 10 million a month - and that includes T2D and pediatric scripts. So is this just a giant sampling issue, or are 20 million patients on compound or RUO? It’s probably a mix of both, but this potentially points to a big issue for pharma. I will note that the same poll indicated that 68% said they were on branded, but it’s possible patients may be shy or not even know the difference. (I’m sure Lilly and Novo are hoping those responses are honest.) That might indicate the real total number of patients on GLP-1s is closer to around 15 million, with just 5 million on compound. 🤷♀️






Semax is the closest thing to a limitless pill I've ever taken. It has 40 years of safe Russian clinical use behind it. I've been using it for a few months and the cognitive benefits are insane. Here's the breakdown: (1/16)




Best start to the week yet. One day this may feel small, but right now it feels huge. Let's have ourselves an epic 4th of July week! Thank you all! Anyway, better late than never to hit the Summer Shred. Enjoy 60% off everything all week w/ code FREEDOM whooshwellness.com

I truly believe that in 5 years Tirzepatide is going to be the best all around GLP solution Reta will be looked at as an aggressive solution for those okay with some trade-offs Semaglutide in my opinion will be looked at like an artifact in a museum Tirzepatide… just right 👌


I truly believe that in 5 years Tirzepatide is going to be the best all around GLP solution Reta will be looked at as an aggressive solution for those okay with some trade-offs Semaglutide in my opinion will be looked at like an artifact in a museum Tirzepatide… just right 👌



I truly believe that in 5 years Tirzepatide is going to be the best all around GLP solution Reta will be looked at as an aggressive solution for those okay with some trade-offs Semaglutide in my opinion will be looked at like an artifact in a museum Tirzepatide… just right 👌







